Actively Recruiting

Age: 18Years - 65Years
All Genders
ID06406972

Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Led by Region Skane · Updated on 2025-08-14

7000

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

Sponsors

R

Region Skane

Lead Sponsor

L

Lund University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a treatment model called Brief Admission by self-referral (BA) designed for individuals with traits of borderline personality disorder who self-harm. This model aims to reduce self-harm and compulsory care by promoting patient autonomy and person-centered care. The study compares different clinics implementing BA at various times, focusing on outcomes related to compulsory care, voluntary inpatient care, and mortality. The treatment involves an individualized contract that allows patients to self-refer for inpatient treatment limited to a maximum of three nights, three times per month. The study uses a register-based observational approach, comparing periods before and after BA implementation across multiple clinics including Lund, Linköping, Helsingborg, and Norrköping. The comparison groups consist of time periods before and after BA implementation at these sites. Participants will be monitored through registry data from September 15, 2010, to December 31, 2025. Researchers will measure days with compulsory admission, days with voluntary psychiatric admission, duration of free intervals between admissions, mortality, and numbers of compulsory and voluntary admissions. This long-term observation will help assess the impact of BA on inpatient care and mortality in this population.

CONDITIONS

Brief Title

Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping
  • Age 18 to 65 years at the time of inclusion
  • Admitted to hospital diagnosed with borderline personality disorder (ICD-10 F60.3), or admitted at least twice with intentional self-harm (X60-83) combined with one or more of the following: ADHD (F90.0-F90.X), Bipolar disorder type 2 (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W), Autism spectrum disorders (F84.0, F84.1, F84.5), or Mild intellectual disability (F70.0-F70.9)
Not Eligible

You will not qualify if you...

  • Not fulfilling the above inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Brief Admission by Self-referral

Duration - Up to 5 years

Participants may self-refer for brief inpatient admissions limited to a maximum of three nights, up to three times per month, through an individualised contract.

Admissions as needed, up to 3 times per month

Long-term Monitoring

Duration - Up to 5 years

Participants are observed over time for outcomes related to compulsory and voluntary psychiatric admissions and other health indicators.

Periodic assessments according to routine care

Trial Site Locations

Total: 4 locations

1

Division of Psychiatry, Region Skåne

Lund, Skåne County, Sweden, 22185

Actively Recruiting

2

Region Östergötland

Linköping, Sweden, 581 91

Actively Recruiting

3

Statistiska centralbyrån

Solna, Sweden, 171 54

Actively Recruiting

4

Socialstyrelsen

Stockholm, Sweden, SE-106 30

Actively Recruiting

Loading map...

Research Team

S

Sofie Sofie, PhD

J

Josefin Vikström Eckevall, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

12

Similar Trials

A Randomised Double-blind Placebo Controlled Investigation o...

Borderline Personality Disorder

Actively Recruiting

1 location

A Novel Peer-Delivered Recovery-Focused Suicide Prevention I...

Psychotic Disorders

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

On the potential for iatrogenic effects of psychiatric crisis services: The example of dialectical behavior therapy for adult women with borderline personality disorder.

Trevor N Coyle, Jennifer A Shaver, Marsha M Linehan

https://pubmed.ncbi.nlm.nih.gov/29369662

A standardized crisis management model for self-harming and suicidal individuals with three or more diagnostic criteria of borderline personality disorder: The Brief Admission Skåne randomized controlled trial protocol (BASRCT).

Sophie I Liljedahl, Marjolein Helleman, Daiva Daukantaité...

https://pubmed.ncbi.nlm.nih.gov/28619050

Effect of Brief Admission to Hospital by Self-referral for Individuals Who Self-harm and Are at Risk of Suicide: A Randomized Clinical Trial.

Sofie Westling, Daiva Daukantaite, Sophie I Liljedahl...

https://pubmed.ncbi.nlm.nih.gov/31173128

Predictable, Collaborative and Safe: Healthcare Provider Experiences of Introducing Brief Admissions by Self-referral for Self-harming and Suicidal Persons with a History of Extensive Psychiatric Inpatient Care.

Rose-Marie Lindkvist, Kajsa Landgren, Sophie I Liljedahl...

https://pubmed.ncbi.nlm.nih.gov/31099707

A randomized controlled trial comparing self-referral to inpatient treatment and treatment as usual in patients with severe mental disorders.

Vidir Sigrunarson, Inger Elise Opheim Moljord, Aslak Steinsbekk...

https://pubmed.ncbi.nlm.nih.gov/27739334

Patient-controlled hospital admission for patients with severe mental disorders: a nationwide prospective multicentre study.

C T Thomsen, M E Benros, T Maltesen...

https://pubmed.ncbi.nlm.nih.gov/29504127